The structure of aggrecan fragments in human synovial fluid. evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis (original) (raw)

Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments1

André Struglics

Osteoarthritis and Cartilage, 2006

View PDFchevron_right

The role of aggrecan in normal and osteoarthritic cartilage

John Mort

Journal of Experimental Orthopaedics, 2014

View PDFchevron_right

Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis

William Fisher

BMC musculoskeletal disorders, 2016

View PDFchevron_right

The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism

John Mort

Biochemical Journal, 2002

View PDFchevron_right

Coincubation of Bovine Synovial or Capsular Tissue with Cartilage Generates a Soluble “Aggrecanase” Activity

David Buttle

Biochemical and Biophysical Research Communications, 1999

View PDFchevron_right

Aggrecan and Cartilage Oligomeric Matrix Protein in Serum and Synovial Fluid of Patients with Knee Osteoarthritis

Ibrahim AL-Shal

Hss Journal, 2010

View PDFchevron_right

A comparison of different purification methods of aggrecan fragments from human articular cartilage and synovial fluid

André Struglics

Matrix Biology, 2010

View PDFchevron_right

ELISA for the core protein of the cartilage large aggregating proteoglycan, aggrecan: Comparison with the concentrations of immunogenic keratan sulphate in synovial fluid, serum and urine

Jens-christian Poulsen

Clinica Chimica Acta, 1994

View PDFchevron_right

Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity

André Struglics

Arthritis research & therapy, 2017

View PDFchevron_right

Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes

George Dodge

Osteoarthritis and Cartilage, 2003

View PDFchevron_right

Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes

G. Verbruggen

Osteoarthritis and Cartilage, 2000

View PDFchevron_right

Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage

Demitrios Vynios

The Biochemical journal, 1996

View PDFchevron_right

Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown

Corinne Gendron

Arthritis Research Therapy, 2005

View PDFchevron_right

Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants

Karena Last

2000

View PDFchevron_right

Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes

jean-luc wautier

Arthritis & Rheumatism, 2006

View PDFchevron_right

Measures of Molecular Composition and Structure in Osteoarthritis

Bernard Dardzinski

Radiologic Clinics of North America, 2009

View PDFchevron_right

The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals

Elina Momin

Journal of the American Veterinary Medical Association, 2005

View PDFchevron_right

Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2)

Priya Chockalingam

Arthritis & Rheumatism, 2004

View PDFchevron_right

Differential histochemical staining of glycosaminoglycans in the matrix of osteoarthritic cartilage

Steen Christensen

Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1980

View PDFchevron_right

Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay

David Buttle

Molecular Pathology, 1997

View PDFchevron_right

Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice

Roger Mason

Arthritis & Rheumatism, 2001

View PDFchevron_right

Chemical and Immunological Assay of the Nonreducing Terminal Residues of Chondroitin Sulfate from Human Aggrecan

Anna Plaas, Peter Roughley, Ronald Midura

Journal of Biological Chemistry, 1997

View PDFchevron_right

The structure, biochemistry, and metabolism of osteoarthritic cartilage: A review of the literature

Lambert de Bont

Journal of Oral and Maxillofacial Surgery, 1995

View PDFchevron_right

Proteoglycans in normal and severely osteoarthritic human cartilage

Nagaswami Vasan

Biochemical Journal, 1980

View PDFchevron_right

Aggrecanase: A Target for the Design of Inhibitors of Cartilage Degradation

Robert Newton

Annals of the New York Academy of Sciences, 1999

View PDFchevron_right

Aggrecan Turnover in Human Articular Cartilage: Use of Aspartic Acid Racemization as a Marker of Molecular Age

Nathali Kaushansky

View PDFchevron_right

Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study

André Struglics

Arthritis Research & Therapy, 2009

View PDFchevron_right

Synovial mesenchymal progenitor derived aggrecan regulates cartilage homeostasis and endogenous repair capacity

Paul Salo

Cell Death & Disease

View PDFchevron_right

Distribution of hyaluronan in articular cartilage as probed by a biotinylated binding region of aggrecan

Markku Tammi

Histochemistry and Cell Biology, 1996

View PDFchevron_right

Modern molecular analysis of a traditional disease: Progression in osteoarthritis

Linda Sandell

Arthritis & Rheumatism, 2007

View PDFchevron_right

Degradation of cartilage aggrecan by collagenase-3 (MMP-13)

Karena Last

FEBS Letters, 1996

View PDFchevron_right

Glycosaminoglycan measured from synovial fluid serves as a useful indicator for progression of Osteoarthritis and complements Kellgren–Lawrence Score

soumya Koppikar

BBA Clinical, 2016

View PDFchevron_right

Activation of neutral metalloprotease in human osteoarthritic knee cartilage: evidence for degradation in the core protein of sulphated proteoglycan

C. Malemud

Annals of the Rheumatic Diseases, 1988

View PDFchevron_right

Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix☆

Gregory Jay

Osteoarthritis and Cartilage, 2003

View PDFchevron_right

Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains

André Struglics

Osteoarthritis and Cartilage, 2011

View PDFchevron_right